Sponsor

Radboud University Medical Center

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Radboud University Medical Center appears in 316 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials316
Recruiting shown12
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Prospective Prostate Cancer InfrastructureNCT07560748 · lead sponsor · 2026-09-01
RECRUITING
Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal ApproachNCT07316296 · lead sponsor · 2026-01-01
RECRUITING
Detection of Minimal Residual Disease Post-prostatectomyNCT07334275 · lead sponsor · 2025-09-16
RECRUITING
Slow-SPEED: Slowing Parkinson's Early Through Exercise DosageNCT06993142 · lead sponsor · 2025-09-01
RECRUITING
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer PatientsNCT06082492 · lead sponsor · 2024-03-19
RECRUITING
Effectiveness of Focal Therapy in Men With Prostate CancerNCT06223295 · lead sponsor · 2024-02-01
RECRUITING
Validation of Rapid On-site Diagnostics in Early Stage Lung Cancer Sampling With a Higher Harmonic Generation MicroscopeNCT06007261 · lead sponsor · 2024-01-19
RECRUITING
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-NetherlandsNCT06193252 · lead sponsor · 2024-01-15
RECRUITING
The Effect of Compensation Strategies on Gait Impairment in Parkinson's DiseaseNCT06142448 · lead sponsor · 2023-12-01
RECRUITING
Neural Control of Breathing in Parkinson's DiseaseNCT06074614 · lead sponsor · 2023-10-30
RECRUITING
STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's DiseaseNCT04848077 · lead sponsor · 2021-05-18
RECRUITING
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.NCT00825929 · lead sponsor · 2009-02-01
RECRUITING
Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With ObesityNCT07504172 · lead sponsor · 2026-04-01
NOT_YET_RECRUITING
App-based Protein Support for Older Adults; Coaching Towards Healthy AgeingNCT07415408 · lead sponsor · 2026-01-12
ENROLLING_BY_INVITATION
RAPIDE: The Feasibility of a Hybrid Care ModelNCT06735404 · lead sponsor · 2026-01-01
NOT_YET_RECRUITING
The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-IINCT06422494 · lead sponsor · 2025-09-28
COMPLETED
Effectiveness of STIL Orthosis in PDNCT06886178 · lead sponsor · 2025-02-19
COMPLETED
An Integrated and Personalized Lifestyle Approach for People With Parkinson's DiseaseNCT06669455 · lead sponsor · 2024-11-12
ACTIVE_NOT_RECRUITING
Enhancement of Quality of Work And LifeNCT06573866 · lead sponsor · 2024-10-08
ACTIVE_NOT_RECRUITING
Determining the Clinical Relevance of the Interaction Between Enzalutamide and the Opioid Morphine and the DOAC EdoxabanNCT05339672 · lead sponsor · 2024-07-01
UNKNOWN
Multi-Omics to Predict the Blood Pressure Response to AntihypertensivesNCT05917275 · lead sponsor · 2024-04-04
UNKNOWN
Tackling Anxiety-related Freezing of Gait in People With Parkinson's DiseaseNCT06302309 · lead sponsor · 2024-04-04
COMPLETED
MItochondrial Diabetes LOw Carb- Diet StudyNCT06185790 · lead sponsor · 2024-01-05
COMPLETED
Optimizing Counceling on Feeding Options of Babies From Mothers Living With HIVNCT06067646 · lead sponsor · 2024-01-01
UNKNOWN
Rivaroxaban Sotorasib Interaction StudyNCT06314763 · lead sponsor · 2023-11-09
COMPLETED
Digital Breast Tomosynthesis for the Dutch National Breast Cancer Screening ProgramNCT06059300 · lead sponsor · 2023-07-17
ACTIVE_NOT_RECRUITING
Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's DiseaseNCT05948761 · lead sponsor · 2023-07-04
COMPLETED
AADC/TDC in Advanced Parkinson's DiseaseNCT05558787 · lead sponsor · 2023-06-28
COMPLETED
The Effects of Mindfulness-based Cognitive Therapy in People With Parkinson's DiseaseNCT05779137 · lead sponsor · 2023-04-17
ACTIVE_NOT_RECRUITING
Super-resolution of Brain Magnetic Resonance Images in Deep Brain Stimulation for Parkinson's DiseaseNCT05596201 · lead sponsor · 2023-03-28
COMPLETED
The GATE Trial: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina DeviceNCT05711043 · lead sponsor · 2023-03-01
UNKNOWN
Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding VolunteersNCT05648201 · lead sponsor · 2023-03-01
COMPLETED
Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to BreastfeedNCT05642481 · lead sponsor · 2023-03-01
COMPLETED
BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota TransplantationNCT05622123 · lead sponsor · 2023-02-23
UNKNOWN
Head-up Tilt Sleeping to Alleviate Orthostatic Hypotension, Supine Hypertension and Nocturia in Parkinson's DiseaseNCT05551377 · lead sponsor · 2023-01-18
UNKNOWN
The GATE Study: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina DeviceNCT05599477 · lead sponsor · 2022-12-01
UNKNOWN
Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided RadiotherapyNCT05373316 · lead sponsor · 2022-12-01
NOT_YET_RECRUITING
Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS.NCT05489406 · lead sponsor · 2022-10-06
COMPLETED
Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLCNCT05555199 · lead sponsor · 2022-10-03
COMPLETED
Asleep MRI-guided Versus Awake Microelectrode Recording Guided Deep Brain Stimulation in Parkinson's Disease: A Comparative Effectiveness TrialNCT05453331 · lead sponsor · 2022-10-01
UNKNOWN
The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor DoravirineNCT05536466 · lead sponsor · 2022-09-30
UNKNOWN
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail ElderlyNCT05529147 · lead sponsor · 2022-09-05
COMPLETED
Evaluation of Contrast Enhanced Breast CT for Diagnosis and Staging of Breast CancerNCT05404087 · lead sponsor · 2022-08-01
UNKNOWN
(In)Voluntary Assessed Quadriceps Muscle Endurance in COPDNCT05427773 · lead sponsor · 2022-07-05
COMPLETED
Quantitative mpMRI to Predict Metastatic Potential of Prostate CancerNCT05252806 · lead sponsor · 2022-07-01
UNKNOWN
Decline in Renal Concentration Ability in Lithium Treated PatientsNCT05307042 · lead sponsor · 2022-05-01
UNKNOWN
MRI-guided Focal Laser Ablation Prostate CancerNCT05370482 · lead sponsor · 2022-04-11
UNKNOWN
Stress Reduction in Formerly Preeclamptic Women; Sofa or SportsNCT06402604 · lead sponsor · 2022-04-01
COMPLETED
Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's DiseaseNCT05214287 · lead sponsor · 2022-02-22
COMPLETED
Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI ChallengeNCT05489341 · lead sponsor · 2022-02-01
COMPLETED
Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCANCT05306184 · lead sponsor · 2022-01-01
ACTIVE_NOT_RECRUITING
The ADAPT-study: Measuring Physical Performance Using Wearable Sensors in Parkinson's Disease and COPD (ADAPT)NCT05756075 · lead sponsor · 2021-12-23
COMPLETED
2000HIV Trained Innate Immunity in HIV Elite ControllersNCT04968717 · lead sponsor · 2021-08-02
COMPLETED
Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound GuidanceNCT04107636 · lead sponsor · 2021-08-02
COMPLETED
Hyperintense: Midlife Hypertension and the BrainNCT06175663 · lead sponsor · 2021-07-06
UNKNOWN
A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell MassNCT04615910 · lead sponsor · 2021-07-01
UNKNOWN
Personalized Parkinson Project PSP CohortNCT05501431 · lead sponsor · 2021-05-01
COMPLETED
Fluid Restriction in Heart Failure Versus Liberal Fluid UptakeNCT04551729 · lead sponsor · 2021-04-21
COMPLETED
Bringing Parkinson Care Back HomeNCT04288583 · lead sponsor · 2021-03-01
UNKNOWN
Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate CancerNCT04717154 · lead sponsor · 2021-01-19
COMPLETED

Drugs studied in this sponsor's trials

83 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Radboud University Medical Center as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo14
raltegravir6
atazanavir2
bevacizumab2
boceprevir2
bosentan2
cholecalciferol2
daclatasvir2
placebo RxCUI 8375 · Lead sponsor in 12 linked trial(s) · 1 currently recruiting 14 trials raltegravir RxCUI 719872 · Lead sponsor in 6 linked trial(s) · 0 currently recruiting 6 trials atazanavir RxCUI 343047 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials bevacizumab RxCUI 253337 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials boceprevir RxCUI 1102129 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials bosentan RxCUI 75207 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials cholecalciferol RxCUI 2418 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials daclatasvir RxCUI 1606218 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials dolutegravir RxCUI 1433868 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials hydrochlorothiazide RxCUI 5487 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials metformin RxCUI 6809 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials nevirapine RxCUI 53654 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials pemetrexed RxCUI 68446 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials phentolamine RxCUI 8153 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials ritonavir RxCUI 85762 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials abacavir RxCUI 190521 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial abiraterone RxCUI 1100072 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial acetaminophen RxCUI 161 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial acetylcholine RxCUI 194 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial acetylcysteine RxCUI 197 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial adenosine RxCUI 296 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial alectinib RxCUI 1727455 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial amlodipine RxCUI 17767 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial amlodipine / olmesartan RxCUI 1009015 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor249
collaborator67
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.